Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
entolimod | toll-like receptor 5 | NA | Clinical trial target | TTD , DGIDB | Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Radiation Syndrome[MeSHID:D011832] |
63.65 | phase 1 | agonist |
entolimod | toll-like receptor 5 | NA | Clinical trial target | TTD , DGIDB | Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Radiation Syndrome[MeSHID:D011832] |
63.65 | phase 1 | unknown |
click here to return to the previous page |